We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+6.74%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$13B
AUM Growth
+$1.56B
Cap. Flow
+$847M
Cap. Flow %
6.54%
Top 10 Hldgs %
18.23%
Holding
2,527
New
188
Increased
1,360
Reduced
792
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 6.93%
2 Financials 4.91%
3 Healthcare 4.18%
4 Consumer Discretionary 3.53%
5 Communication Services 3.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAT
2351
DELISTED
FAT Brands
FAT
$46K ﹤0.01%
20,679
-425
-2% -$1.04K
HEXO
2352
DELISTED
HEXO Corp. Common Shares
HEXO
$46K ﹤0.01%
513
-30
-6% -$3.95K
ATHX
2353
DELISTED
Athersys, Inc. Common Stock
ATHX
$46K ﹤0.01%
1,502
AHT
2354
Ashford Hospitality Trust
AHT
$20.3M
$44K ﹤0.01%
16
RRD
2355
DELISTED
RR Donnelley & Sons Co.
RRD
$42K ﹤0.01%
10,586
-4,551
-30% -$18K
HL icon
2356
Hecla Mining
HL
$11.9B
$40K ﹤0.01%
11,811
+302
+3% +$741
WKHS icon
2357
Workhorse Group
WKHS
$34.1M
$40K ﹤0.01%
+4
New +$36.8K
SMRT
2358
DELISTED
Stein Mart Inc
SMRT
$40K ﹤0.01%
59,375
DXYN
2359
DELISTED
Dixie Group Inc
DXYN
$36K ﹤0.01%
32,007
+10,000
+45% +$14.6K
NBR icon
2360
Nabors Industries
NBR
$1.3B
$34K ﹤0.01%
+234
New +$24.6K
NBEV
2361
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$34K ﹤0.01%
18,760
+1,425
+8% +$3.37K
LUMO
2362
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$33K ﹤0.01%
+1,448
New +$20.7K
GPOR
2363
DELISTED
Gulfport Energy Corp.
GPOR
$33K ﹤0.01%
10,739
+479
+5% +$1.36K
REI icon
2364
Ring Energy
REI
$357M
$32K ﹤0.01%
12,200
-500
-4% -$981
WATT icon
2365
Energous
WATT
$103M
$32K ﹤0.01%
31
-1
-3% -$1.49K
WPRT
2366
Westport Fuel Systems
WPRT
$36.7M
$32K ﹤0.01%
1,366
-40
-3% -$1.02K
CLNE icon
2367
Clean Energy Fuels
CLNE
$377M
$30K ﹤0.01%
12,899
-1,700
-12% -$3.61K
SJT
2368
San Juan Basin Royalty Trust
SJT
$126M
$29K ﹤0.01%
11,613
+884
+8% +$2.23K
CTST
2369
DELISTED
CannTrust Holdings Inc. Common Share
CTST
$29K ﹤0.01%
31,000
-315
-1% -$313
CNVS icon
2370
Cineverse
CNVS
$64.9M
$28K ﹤0.01%
1,983
-2,653
-57% -$45.7K
TURN
2371
DELISTED
180 Degree Capital
TURN
$28K ﹤0.01%
4,308
HCR
2372
DELISTED
Hi-Crush Inc. Common Stock
HCR
$27K ﹤0.01%
30,599
+645
+2% +$681
IDXG
2373
DELISTED
Interpace Biosciences, Inc. Common Stock
IDXG
$27K ﹤0.01%
5,490
+780
+17% +$5.05K
CARM
2374
DELISTED
Carisma Therapeutics
CARM
$26K ﹤0.01%
1,250
BFX
2375
DELISTED
BowFlex Inc.
BFX
$26K ﹤0.01%
15,000

Similar funds

Cambridge Investment Research Advisors's Q4 2019 Portfolio in Review

As of Q4 2019, Cambridge Investment Research Advisors held 2,527 positions worth $13B, up 14% from $11.4B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Cambridge Investment Research Advisors deployed $847M of net new capital in Q4 2019, opening 188 new positions and adding to 1,360 existing holdings. Its largest new stake was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.

By sector, the portfolio is most concentrated in Technology at 6.9% of assets, up from 6.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $23.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2019 buy was PIMCO 15+ Year US TIPS Index Exchange-Traded Fund: 76,384 shares worth $5.5M.
  • Cambridge Investment Research Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q4 2019, an estimated $38.2M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2019 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $23.2M.
  • Cambridge Investment Research Advisors fully exited Celgene Corp in Q4 2019, selling an estimated $13.9M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 18% of its $13B portfolio in Q4 2019.
  • Cambridge Investment Research Advisors opened 188 new positions and closed 124 in Q4 2019.
  • Cambridge Investment Research Advisors's portfolio value rose 14% quarter-over-quarter to $13B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2019, filed 4 Feb 2020.